IT1217783B - Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative - Google Patents

Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative

Info

Publication number
IT1217783B
IT1217783B IT20859/88A IT2085988A IT1217783B IT 1217783 B IT1217783 B IT 1217783B IT 20859/88 A IT20859/88 A IT 20859/88A IT 2085988 A IT2085988 A IT 2085988A IT 1217783 B IT1217783 B IT 1217783B
Authority
IT
Italy
Prior art keywords
salo
dell
butyric
alcoholic
therapy
Prior art date
Application number
IT20859/88A
Other languages
English (en)
Other versions
IT8820859A0 (it
Inventor
S L Gessa
F Fadda
C Mormile
Original Assignee
Farmaceutico Ct S R L Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutico Ct S R L Lab filed Critical Farmaceutico Ct S R L Lab
Publication of IT8820859A0 publication Critical patent/IT8820859A0/it
Priority to IT20859/88A priority Critical patent/IT1217783B/it
Priority to ES89109712T priority patent/ES2075011T3/es
Priority to ZA894128A priority patent/ZA894128B/xx
Priority to EP89109712A priority patent/EP0344704B1/en
Priority to AT89109712T priority patent/ATE126433T1/de
Priority to DE68923819T priority patent/DE68923819T2/de
Priority to AU35904/89A priority patent/AU633002B2/en
Priority to DK198902723A priority patent/DK174017B1/da
Priority to PT90732A priority patent/PT90732B/pt
Priority to NO89892270A priority patent/NO892270L/no
Priority to CA000601648A priority patent/CA1330423C/en
Priority to NZ229399A priority patent/NZ229399A/en
Priority to AR89314068A priority patent/AR241512A1/es
Priority to US07/361,490 priority patent/US4983632A/en
Priority to FI892718A priority patent/FI892718A/fi
Priority to IE178589A priority patent/IE68685B1/en
Application granted granted Critical
Publication of IT1217783B publication Critical patent/IT1217783B/it
Priority to GR950403119T priority patent/GR3018009T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
IT20859/88A 1988-06-03 1988-06-03 Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative IT1217783B (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT20859/88A IT1217783B (it) 1988-06-03 1988-06-03 Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
ES89109712T ES2075011T3 (es) 1988-06-03 1989-05-30 Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
ZA894128A ZA894128B (en) 1988-06-03 1989-05-30 Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
EP89109712A EP0344704B1 (en) 1988-06-03 1989-05-30 Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained
AT89109712T ATE126433T1 (de) 1988-06-03 1989-05-30 Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
DE68923819T DE68923819T2 (de) 1988-06-03 1989-05-30 Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
AU35904/89A AU633002B2 (en) 1988-06-03 1989-06-01 Use of gamma-hydroxybutyric acid salts in the treatment of alcoholism and pharmaceutical compositions thereof
PT90732A PT90732B (pt) 1988-06-03 1989-06-02 Processo para a preparacao de composicoes farmaceuticas adequadas para serem empregues na terapia do alcoolismo, a base de sais do acido gama-hidroxibutirico
DK198902723A DK174017B1 (da) 1988-06-03 1989-06-02 Anvendelse af gamma-hydroxysmørsyresalte til fremstilling af farmaceutiske præparater til behandling af alkoholisme
NO89892270A NO892270L (no) 1988-06-03 1989-06-02 Fremgangsmaate for fremstilling av preparater for anvendelse ved behandlingen av alkoholisme.
CA000601648A CA1330423C (en) 1988-06-03 1989-06-02 Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained
NZ229399A NZ229399A (en) 1988-06-03 1989-06-02 Pharmaceutical compositions comprising gamma-hydroxy-butyric acid salts
AR89314068A AR241512A1 (es) 1988-06-03 1989-06-02 Un procedimiento para la preparacion de composiciones utiles para la terapia del alcolismo.
US07/361,490 US4983632A (en) 1988-06-03 1989-06-02 Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained
FI892718A FI892718A (fi) 1988-06-03 1989-06-02 Foerfarande foer framstaellning av farmaceutiska kompositioner foer anvaendning vid behandling av alkoholism.
IE178589A IE68685B1 (en) 1988-06-03 1989-06-12 Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism and the compositions obtained
GR950403119T GR3018009T3 (en) 1988-06-03 1995-11-08 Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20859/88A IT1217783B (it) 1988-06-03 1988-06-03 Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative

Publications (2)

Publication Number Publication Date
IT8820859A0 IT8820859A0 (it) 1988-06-03
IT1217783B true IT1217783B (it) 1990-03-30

Family

ID=11173141

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20859/88A IT1217783B (it) 1988-06-03 1988-06-03 Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative

Country Status (16)

Country Link
US (1) US4983632A (it)
EP (1) EP0344704B1 (it)
AR (1) AR241512A1 (it)
AT (1) ATE126433T1 (it)
AU (1) AU633002B2 (it)
CA (1) CA1330423C (it)
DE (1) DE68923819T2 (it)
DK (1) DK174017B1 (it)
ES (1) ES2075011T3 (it)
FI (1) FI892718A (it)
GR (1) GR3018009T3 (it)
IT (1) IT1217783B (it)
NO (1) NO892270L (it)
NZ (1) NZ229399A (it)
PT (1) PT90732B (it)
ZA (1) ZA894128B (it)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153219A (en) * 1991-04-22 1992-10-06 Morris D. Faiman Thiocarbamate sulfoxide composition for deterring ethanol ingestion
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
WO1993002682A1 (en) * 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
US5366990A (en) * 1991-11-14 1994-11-22 Reid Larry D Method for treating alcohol abuse and alcoholism
IT1261432B (it) * 1993-03-26 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l- carnitina gammaidrossibutirrato per il trattamento dell'alcolismo.
IT1261485B (it) * 1993-06-24 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
IT1283782B1 (it) * 1996-08-09 1998-04-30 Ct Lab Farm Srl Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo
EP1316309A1 (en) * 1998-12-23 2003-06-04 Orphan Medical Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
JP4374441B2 (ja) 1998-12-23 2009-12-02 ジェイピーアイ コマーシャル，リミティド ライアビリティ カンパニー 睡眠発作治療のための、ガンマ−ヒドロキシ酪酸塩の微生物的に安全で安定な液剤
JP4723143B2 (ja) 1999-09-14 2011-07-13 テファ， インコーポレイテッド γ−ヒドロキシブチレートを含むポリマーおよびオリゴマーの治療的用途
ITMI20020754A1 (it) * 2002-04-09 2003-10-09 Aboca S P A Composizioni effervescenti contenenti succhi di frutta essicati
EP2860292B1 (en) 2003-05-08 2020-07-22 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
EP1778305B1 (en) 2004-08-03 2010-07-07 Tepha, Inc. Non-curling polyhydroxyalkanoate sutures
US7838556B2 (en) * 2006-02-21 2010-11-23 University Of Maryland, Baltimore Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands
US20100144885A1 (en) * 2006-09-29 2010-06-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism
US7943683B2 (en) 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
BR112012024019B1 (pt) 2010-03-24 2021-10-19 Jazz Phamaceuticals, Inc Forma de dosagem de liberação controlada para administração oral
CA2798178C (en) * 2010-05-04 2017-06-13 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US9050302B2 (en) 2013-03-01 2015-06-09 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
AU2019383389A1 (en) 2018-11-19 2021-05-06 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044801B1 (de) * 1980-07-17 1984-02-15 Josef Dr. Klosa Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel

Also Published As

Publication number Publication date
PT90732A (pt) 1989-12-29
AU633002B2 (en) 1993-01-21
US4983632A (en) 1991-01-08
NO892270D0 (no) 1989-06-02
GR3018009T3 (en) 1996-02-29
IT8820859A0 (it) 1988-06-03
EP0344704B1 (en) 1995-08-16
DK272389A (da) 1989-12-04
DE68923819T2 (de) 1996-01-18
AU3590489A (en) 1989-12-07
AR241512A1 (es) 1992-08-31
ES2075011T3 (es) 1995-10-01
NO892270L (no) 1989-12-04
NZ229399A (en) 1997-02-24
CA1330423C (en) 1994-06-28
ZA894128B (en) 1990-03-28
PT90732B (pt) 1994-10-31
DK272389D0 (da) 1989-06-02
FI892718A0 (fi) 1989-06-02
EP0344704A1 (en) 1989-12-06
FI892718A (fi) 1989-12-04
DK174017B1 (da) 2002-04-15
ATE126433T1 (de) 1995-09-15
DE68923819D1 (de) 1995-09-21

Similar Documents

Publication Publication Date Title
IT1217783B (it) Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
EP0232849A3 (en) Pyrrolidineamide derivative of acylamino acid, pharmaceutical composition and use
IT1221079B (it) Derivati di anilina terapeuticamente attivi,procedimento per la loro preparazione e composizioni farmaceutiche che il contengono
AU6328586A (en) Novel enolamides, pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascade
AU1283588A (en) New pharmaceutical compositions in the form of beadlets and method
IT8468281A0 (it) Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
IT8720389A0 (it) Esteri retinoici di antibiotici, loro procedimento di preparazione e composizioni farmaceutiche e cosmetiche che li contengono.
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.
IT8920358A0 (it) Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IT1204571B (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
IL109093A0 (en) Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
IT8148166A0 (it) Ne e loro uso terapeutico esteri di mercaptoacil-carnitine procedimento per la loro preparazio
IT1186754B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8 fenil-10 antrone-9,e procedimento di preparazione dell'ingrediente attivo
IT8103423A0 (it) Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono
IT7949403A0 (it) Imminotiazolil ureido cefalosporine composizioni farmaceutiche che le contengono e procedimento per la loro preparazione
IT1164027B (it) Procedimento per la preparazione di cloridrati di amminoacidi e bicloridrati di diamminoacidi
IT8622877A0 (it) Esteri dell'azoniaspironortropanolo, procedimento per la loro preparazione, mezzi farmaceutici che li contengono e impiego di esteri dell'azoniaspironortropanolo come spasmolitico, asmaterapeutico e broncolitico.
IT1214729B (it) Derivati di acido tiofenacetico,procedimento per la loro preparazione, composizioni farmaceutiche che licontengono e loro impiego come medicamenti
IT8520515A0 (it) Composizioni di farmaci eprocedimento per la loro preparazione.
IT8321704A0 (it) Derivato idrosolubile del1-(2-idrossietil)-2-metil-5-nitroimidazolo ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche
DE3564806D1 (en) Benzoylpropionic acid derivatives, their use and pharmaceutical compositions
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
ITMI913398A1 (it) Derivati dell'eserolina ad attivita' anticolinesterasica procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8521662A0 (it) Derivato dell'acido chinolin-3-carbossilico, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono.
IT8419262A0 (it) Esteri della l-carnitina e della l-acetilcarnitina, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970630